Maxim Markovic

3.3k total citations · 2 hit papers
7 papers, 1.6k citations indexed

About

Maxim Markovic is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Maxim Markovic has authored 7 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Maxim Markovic's work include Phagocytosis and Immune Regulation (4 papers), Immune Cell Function and Interaction (3 papers) and Cancer Genomics and Diagnostics (2 papers). Maxim Markovic is often cited by papers focused on Phagocytosis and Immune Regulation (4 papers), Immune Cell Function and Interaction (3 papers) and Cancer Genomics and Diagnostics (2 papers). Maxim Markovic collaborates with scholars based in United States, India and Taiwan. Maxim Markovic's co-authors include Irving L. Weissman, Amira Barkal, Layla J. Barkal, Oliver Dorigo, Venkatesh Krishnan, Balyn W. Zaro, Rachel Brewer, Mark Kowarsky, Jason Hatakeyama and Kevin S. Kao and has published in prestigious journals such as Nature, Nature Communications and Nature Immunology.

In The Last Decade

Maxim Markovic

7 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy

2019 956 citations Amira Barkal, Rachel Brewer et al. Nature profile →
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy

2017 428 citations Amira Barkal, Kipp Weiskopf et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maxim Markovic United States	6	1.2k	558	482	154	135	7	1.6k
Amira Barkal United States	9	1.2k 1.0×	939 1.7×	544 1.1×	188 1.2×	129 1.0×	11	2.0k
Jason Hatakeyama United States	13	702 0.6×	678 1.2×	390 0.8×	176 1.1×	69 0.5×	17	1.3k
Oliver Dorigo United States	10	888 0.8×	612 1.1×	561 1.2×	149 1.0×	69 0.5×	13	1.5k
Jessica Dal Col Italy	20	550 0.5×	469 0.8×	554 1.1×	125 0.8×	98 0.7×	35	1.2k
Rachel Brewer United States	3	663 0.6×	408 0.7×	315 0.7×	107 0.7×	67 0.5×	3	1.0k
Minu K. Srivastava United States	18	1.3k 1.1×	480 0.9×	960 2.0×	209 1.4×	65 0.5×	52	2.0k
Gregory K. Behbehani United States	19	482 0.4×	957 1.7×	366 0.8×	144 0.9×	134 1.0×	58	1.5k
Konstantin Knoblich United States	15	708 0.6×	447 0.8×	509 1.1×	113 0.7×	46 0.3×	19	1.4k
Wenzhi Tian China	16	695 0.6×	292 0.5×	431 0.9×	73 0.5×	95 0.7×	53	1.1k
Miriam R. Fein United States	5	769 0.7×	336 0.6×	492 1.0×	144 0.9×	37 0.3×	8	1.2k

Countries citing papers authored by Maxim Markovic

Since Specialization

Citations

This map shows the geographic impact of Maxim Markovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim Markovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim Markovic more than expected).

Fields of papers citing papers by Maxim Markovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxim Markovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim Markovic. The network helps show where Maxim Markovic may publish in the future.

Co-authorship network of co-authors of Maxim Markovic

This figure shows the co-authorship network connecting the top 25 collaborators of Maxim Markovic. A scholar is included among the top collaborators of Maxim Markovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxim Markovic. Maxim Markovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Rovira‐Clavé, Xavier, Alexandros P. Drainas, Sizun Jiang, et al.. (2022). Spatial epitope barcoding reveals clonal tumor patch behaviors. Cancer Cell. 40(11). 1423–1439.e11. 18 indexed citations

2.

Bai, Yunhao, Bokai Zhu, Xavier Rovira‐Clavé, et al.. (2021). Adjacent Cell Marker Lateral Spillover Compensation and Reinforcement for Multiplexed Images. Frontiers in Immunology. 12. 652631–652631. 29 indexed citations

3.

Rovira‐Clavé, Xavier, Alexandros P. Drainas, Sizun Jiang, et al.. (2021). Spatial Epitope Barcoding Reveals Subclonal Tumor Patch Behaviors. SSRN Electronic Journal. 2 indexed citations

4.

Myers, Lara, Michal Caspi Tal, Laughing Bear Torrez Dulgeroff, et al.. (2019). A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression. Nature Communications. 10(1). 794–794. 41 indexed citations

5.

Barkal, Amira, Rachel Brewer, Maxim Markovic, et al.. (2019). CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 572(7769). 392–396. 956 indexed citations breakdown →

6.

Feng, Mingye, Kristopher D. Marjon, Fangfang Zhu, et al.. (2018). Programmed cell removal by calreticulin in tissue homeostasis and cancer. Nature Communications. 9(1). 3194–3194. 129 indexed citations

7.

Barkal, Amira, Kipp Weiskopf, Kevin S. Kao, et al.. (2017). Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy. Nature Immunology. 19(1). 76–84. 428 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact